4//SEC Filing
K-V Pharmaceutical Co 4
Accession 0001187302-13-000002
CIK 0000057055operating
Filed
Oct 24, 8:00 PM ET
Accepted
Oct 25, 11:31 AM ET
Size
10.2 KB
Accession
0001187302-13-000002
Insider Transaction Report
Form 4
K-V Pharmaceutical CoKVA/KVB
MAHADY JOSEPH M
Director
Transactions
- Award
Option to Purchase
2013-09-27+30,000→ 30,000 totalExercise: $28.80Exp: 2020-09-27→ Common Stock (30,000 underlying) - Award
Restricted Stock
2013-09-27+7,142→ 7,142 totalExercise: $0.00→ Common Stock (7,142 underlying) - Award
Option to Purchase
2013-09-27+10,000→ 10,000 totalExercise: $32.00Exp: 2020-09-27→ Common Stock (10,000 underlying)
Footnotes (3)
- [F1]The option vests 25% on September 27, 2013, 25% on September 27, 2014, 25% on September 27, 2015 and 25% on September 27, 2016, but does not become exercisable until the earliest of January 1, 2019, a change in control of the company or termination without cause of Mr. Mahady's service as a member of the Board of Directors.
- [F2]The option vests 25% on September 27, 2013, 25% on September 27, 2014, 25% on September 27, 2015 and 25% on September 27, 2016, but does not become exercisable until the earliest of January 1, 2019, a change in control of the company or termination without cause of Mr. Mahady's service as a member of the Board of Directors.
- [F3]The restricted stock will not be delivered to Mr. Mahady until the earliest to occur of Mr. Mahady's separation from service with the company, a change in control of the company or January 1, 2019.
Documents
Issuer
K-V Pharmaceutical Co
CIK 0000057055
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000057055
Filing Metadata
- Form type
- 4
- Filed
- Oct 24, 8:00 PM ET
- Accepted
- Oct 25, 11:31 AM ET
- Size
- 10.2 KB